FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
NRx Pharmaceuticals, Inc. FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC,…
#NewsBeep #News #Medication #ANDAapproval #AU #Australia #certification #drugproduct #drug-related #FDA #Health #Inc #ketaminedrug #NRxPharmaceuticals #TheCompany
https://www.newsbeep.com/au/847115/